EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity

Alan D Widgerow

Journal of Drugs in Dermatology · 01.03.2026 · 25 (3) · 268-272

DOI: 10.36849/jdd.9677 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.02.2026. Verfasst von Alan D Widgerow. Hauptthemen laut MEDLINE: Skin Aging, Cellular Senescence, Skin. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin AgingCellular SenescenceSkinHumansFemaleWater Loss, InsensibleAnimalsAgedMaleExtracellular MatrixMiddle AgedEpidermisFibroblasts

Zitieren

APA

Widgerow, A. D. (2026). Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity. Journal of Drugs in Dermatology, 25(3), 268-272. https://doi.org/10.36849/jdd.9677

Vancouver

Widgerow AD. Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity. Journal of Drugs in Dermatology. 2026;25(3):268-272. doi:10.36849/jdd.9677

BibTeX
@article{Widgerow2026,
  author = {Widgerow, Alan D},
  title = {Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  volume = {25},
  number = {3},
  pages = {268--272},
  doi = {10.36849/jdd.9677}
}
Kostenlos starten →